Age and Economics: Should Expensive Procedures Be Limited on the Basis of Age?
WASHINGTON POST HEALTH 4(4): 11, 26 January 1988
Showing items related by title, author, creator and subject.
Ioannidis, John P.A. (2009-01-20)
The Public Funding of Expensive Cancer Therapies: Synthesizing the "3Es" -- Evidence, Economics, and Ethics Kirby, Jeffrey; Somers, Emily; Simpson, Christy; McPhee, Judy (2007-09)
Adding an Expensive Drug to the Formulary -- Scenario; Position 1: Pharmacist Should Support Addition of the Drug; Position 2: Pharmacist Should Not Support Addition of the Drug; Analysis and Commentary Uretsky, Samuel D.; Kaatz, Brian L.; Veatch, Robert M. (1993-08)